Zobrazeno 1 - 10
of 27
pro vyhledávání: '"van Seventer EE"'
Autor:
Parikh AR; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Chee BH; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California., Tsai J; Guardant Health, Palo Alto, California., Rich TA; Guardant Health, Palo Alto, California., Price KS; Guardant Health, Palo Alto, California., Patel SA; Guardant Health, Palo Alto, California., Zhang L; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Medicine, University of California, San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Ibrahim F; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California., Esquivel M; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California., Van Seventer EE; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California., Jarnagin JX; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Raymond VM; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Corvera CU; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California., Hirose K; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California., Nakakura EK; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California., Corcoran RB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Van Loon K; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California., Atreya CE; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 2964-2973.
Autor:
Corcoran RB; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Do KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim JE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Parikh AR; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Yeku OO; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Weekes CD; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Veneris J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ahronian LG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Mauri G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, and Department of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Tian J; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Norden BL; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Michel AG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Van Seventer EE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Siravegna G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Camphausen K; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Chi G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Fetter IJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Chen H; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland., Takebe N; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland., Penson RT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Juric D; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Flaherty KT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Sullivan RJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Clark JW; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Heist RS; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1739-1749.
Autor:
Jarnagin JX; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Saraf A; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston., Baiev I; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Chi G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., van Seventer EE; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Mojtahed A; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston., Allen JN; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Clark JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Blaszkowsky L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Giantonio BJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Weekes CD; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Klempner SJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Franses JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Roeland EJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Goyal L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Siravegna G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Horick N; Department of Statistics, Massachusetts General Hospital and Harvard Medical School, Boston., Corcoran RB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston., Nipp RD; OU Health Stephenson Cancer Center, Section of Hematology and Oncology, Department of Internal Medicine, The University of Oklahoma (OU) College of Medicine, Oklahoma City., Parikh AR; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Nov 01; Vol. 6 (11), pp. e2343512. Date of Electronic Publication: 2023 Nov 01.
Autor:
Tian J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Chen JH; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Chao SX; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Pelka K; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes Department of Microbiology and Immunology, UCSF, San Francisco, CA, USA., Giannakis M; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Hess J; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Burke K; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Jorgji V; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Sindurakar P; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Braverman J; The Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA., Mehta A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Oka T; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Huang M; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Lieb D; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Spurrell M; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Allen JN; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Abrams TA; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Clark JW; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Enzinger AC; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Enzinger PC; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Klempner SJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., McCleary NJ; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Meyerhardt JA; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Ryan DP; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Yurgelun MB; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Kanter K; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Van Seventer EE; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Baiev I; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Chi G; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Jarnagin J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Bradford WB; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Wong E; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Michel AG; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Fetter IJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Siravegna G; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Gemma AJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Sharpe A; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Demehri S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Leary R; Novartis Institute for Biomedical Research, Cambridge, MA, USA., Campbell CD; Novartis Institute for Biomedical Research, Cambridge, MA, USA., Yilmaz O; The Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA., Getz GA; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Parikh AR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Hacohen N; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. NHACOHEN@mgh.harvard.edu.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA. NHACOHEN@mgh.harvard.edu., Corcoran RB; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. rbcorcoran@partners.org.
Publikováno v:
Nature medicine [Nat Med] 2023 Feb; Vol. 29 (2), pp. 458-466. Date of Electronic Publication: 2023 Jan 26.
Autor:
Rajurkar M; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Parikh AR; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Solovyov A; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., You E; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Kulkarni AS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Chu C; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Xu KH; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Jaicks C; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Taylor MS; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Wu C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts., Alexander KA; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Good CR; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Szabolcs A; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Gerstberger S; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Tran AV; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Xu N; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Ebright RY; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Van Seventer EE; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Vo KD; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Tai EC; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Lu C; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Joseph-Chazan J; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Raabe MJ; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Nieman LT; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Desai N; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Arora KS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Ligorio M; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Thapar V; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Cohen L; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts., Garden PM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts., Senussi Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts., Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts., Allen JN; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Blaszkowsky LS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Clark JW; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Goyal L; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Wo JY; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Ryan DP; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Corcoran RB; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Deshpande V; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Rivera MN; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Aryee MJ; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Hong TS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Berger SL; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Walt DR; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts., Burns KH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Greenbaum BD; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, New York., Ting DT; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Jun 02; Vol. 12 (6), pp. 1462-1481.
Autor:
Marquardt JP; Department of Radiology, RWTH Aachen University, Aachen, Germany.; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA., Roeland EJ; Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR, USA., Van Seventer EE; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Best TD; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Radiology, Berlin, Germany., Horick NK; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Nipp RD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Fintelmann FJ; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.
Publikováno v:
Journal of cachexia, sarcopenia and muscle [J Cachexia Sarcopenia Muscle] 2022 Feb; Vol. 13 (1), pp. 190-202. Date of Electronic Publication: 2021 Nov 02.
Autor:
Loomans-Kropp HA; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850., Song Y; Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Gala M; Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114., Parikh AR; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114., Van Seventer EE; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114., Alvarez R; Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048., Hitchins MP; Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850., Umar A; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Feb; Vol. 2 (2), pp. 90-98. Date of Electronic Publication: 2022 Feb 11.
Autor:
Kanter K; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Fish M; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Mauri G; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano (La Statale), Milan, Italy., Horick NK; Department of Statistics, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Allen JN; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Blaszkowsky LS; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Clark JW; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Ryan DP; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Nipp RD; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Giantonio BJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Goyal L; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Dubois J; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Murphy JE; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Franses J; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Klempner SJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Roeland EJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Weekes CD; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Hong TS; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Van Seventer EE; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Corcoran RB; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA., Parikh AR; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2021 Dec; Vol. 17 (12), pp. e1846-e1855. Date of Electronic Publication: 2021 May 27.
Autor:
Parikh AR; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Szabolcs A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Allen JN; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Clark JW; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Raabe M; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Thel H; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Hoyos D; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mehta A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; The Broad Institute, Cambridge, MA, USA., Arshad S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Lieb DJ; The Broad Institute, Cambridge, MA, USA., Drapek LC; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Blaszkowsky LS; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Giantonio BJ; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Weekes CD; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Zhu AX; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Goyal L; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Nipp RD; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Dubois JS; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Van Seventer EE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Foreman BE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Matlack LE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Ly L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Meurer JA; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Hacohen N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; The Broad Institute, Cambridge, MA, USA., Ryan DP; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Yeap BY; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Corcoran RB; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Greenbaum BD; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ting DT; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA. dting1@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. dting1@mgh.harvard.edu., Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. tshong1@mgh.harvard.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2021 Nov; Vol. 2 (11), pp. 1124-1135. Date of Electronic Publication: 2021 Nov 18.
Autor:
Parikh AR; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Van Seventer EE; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Siravegna G; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Hartwig AV; Guardant Health, Inc, Redwood City, California., Jaimovich A; Guardant Health, Inc, Redwood City, California., He Y; Guardant Health, Inc, Redwood City, California., Kanter K; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Fish MG; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Fosbenner KD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Miao B; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Phillips S; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Carmichael JH; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Sharma N; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Jarnagin J; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Baiev I; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Shah YS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Fetter IJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Shahzade HA; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Allen JN; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Blaszkowsky LS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Clark JW; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Dubois JS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Franses JW; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Giantonio BJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Goyal L; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Klempner SJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Nipp RD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Roeland EJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Ryan DP; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Weekes CD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Hong TS; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Bordeianou L; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts., Ferrone CR; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts., Qadan M; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Kunitake H; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts., Berger D; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts., Ricciardi R; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts., Cusack JC; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Raymond VM; Guardant Health, Inc, Redwood City, California., Talasaz A; Guardant Health, Inc, Redwood City, California., Boland GM; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Corcoran RB; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts. rbcorcoran@partners.org.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 15; Vol. 27 (20), pp. 5586-5594. Date of Electronic Publication: 2021 Apr 29.